Ligand–Receptor Interactions and Structure–Function Relationships in Off-Target Binding of the β3-Adrenergic Agonist Mirabegron to α1A-Adrenergic Receptors
International Journal of Molecular Sciences · 07.07.2024 · 25 (13) · 7468
DOI: 10.3390/ijms25137468 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.07.2024. Verfasst von Ru Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510180, China. Hauptthemen laut MEDLINE: Acetanilides, Thiazoles, Receptors, Adrenergic, alpha-1, Adrenergic beta-3 Receptor Agonists. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The β3-adrenoceptor agonist mirabegron is available for the treatment of storage symptoms of overactive bladder, including frequency, urgency, and incontinence. The off-target effects of mirabegron include binding to α1-adrenoceptors, which are central in the treatment of voiding symptoms. Here, we examined the structure–function relationships in the binding of mirabegron to a cryo-electron microscopy structure of α1A. The binding was simulated by docking mirabegron to a 3D structure of a human α1A-adrenoceptor (7YMH) using Autodock Vina. The simulations identified two binding states: slope orientation involving 10 positions and horizontal binding to the receptor surface involving 4 positions. No interactions occurred with positions constituting the α1A binding pocket, including Asp-106, Ser-188, or Phe-312, despite the positioning of the phenylethanolamine moiety in transmembrane regions close to the binding pocket by contact with Phe-288, -289, and Val-107. Contact with the unique positions of α1A included the transmembrane Met-292 during slope binding and exosite Phe-86 during horizontal binding. Exosite binding in slope orientation involved contact of the anilino part, rather than the aminothiazol end, to Ile-178, Ala-103, and Asn-179. In conclusion, contact with Met-292 and Phe-86, which are unique positions of α1A, accounts for mirabegron binding to α1A. Because of its lack of interactions with the binding pocket, mirabegron has lower affinity compared to α1A-blockers and no effects on voiding symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510180, China.
- Department of Urology, LMU University Hospital, LMU Munich, 80539 Munich, Germany.
- Urologische Klinik und Poliklinik, Marchioninistr. 15, 81377 Munich, Germany.
ORCID-Profile: Ru Huang, Alexander Tamalunas
Zitieren
APA
Huang, R., Yu, Q., Tamalunas, A., Stief, C. G., & Hennenberg, M. (2024). Ligand–Receptor Interactions and Structure–Function Relationships in Off-Target Binding of the β3-Adrenergic Agonist Mirabegron to α1A-Adrenergic Receptors. International Journal of Molecular Sciences, 25(13), 7468. https://doi.org/10.3390/ijms25137468
Vancouver
Huang R, Yu Q, Tamalunas A, Stief CG, Hennenberg M. Ligand–Receptor Interactions and Structure–Function Relationships in Off-Target Binding of the β3-Adrenergic Agonist Mirabegron to α1A-Adrenergic Receptors. International Journal of Molecular Sciences. 2024;25(13):7468. doi:10.3390/ijms25137468
BibTeX
@article{Huang2024,
author = {Huang, Ru and Yu, Qingfeng and Tamalunas, Alexander and Stief, Christian G and Hennenberg, Martin},
title = {Ligand–Receptor Interactions and Structure–Function Relationships in Off-Target Binding of the β3-Adrenergic Agonist Mirabegron to α1A-Adrenergic Receptors},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {13},
pages = {7468},
doi = {10.3390/ijms25137468}
}
EUVIMED